The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for weight loss and diabetes.

to find a partner that can help them compete in the weight loss drug market with pharmaceutical behemoths like Eli Lilly. Guggenheim's Fernandez said disappointing data or any safety issues that ...